Supplemental Stockholders' Equity Information (Tables)

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Schedule of Changes in Accumulated Other Comprehensive Loss

The following table summarizes the changes in AOCI by component as of March 31, 2024:

(In thousands)	Foreign Currency Translation Adjustments		Funded Status of Benefit Plans		Net Unrealized Loss on Available-For-Sale Securities		Total Accumulated Other Comprehensive Loss
Balance as of December 31, 2023	$	910	$	(353,286)	$	(486)	$	(352,862)
Other comprehensive loss before reclassifications, before tax	(1,846)		—		(709)		(2,555)
Amounts reclassified from accumulated other comprehensive loss, before tax	—		3,288		—		3,288
Income tax (benefit)/expense	(483)		899		(186)		230
Net current-period other comprehensive (loss)/income, net of tax	(1,363)		2,389		(523)		503
Balance as of March 31, 2024	$	(453)	$	(350,897)	$	(1,009)	$	(352,359)

Schedule of Reclassification out of Accumulated Other Comprehensive Income

The following table summarizes the reclassifications from AOCI for the three months ended March 31, 2024:

(In thousands) Detail about accumulated other comprehensive loss components	Amounts reclassified from accumulated other comprehensive loss		Affects line item in the statement where net income is presented
Funded status of benefit plans:
Amortization of prior service credit (1)	$	(486)	Other components of net periodic benefit costs/(income)
Amortization of actuarial loss (1)	3,774		Other components of net periodic benefit costs/(income)
Total reclassification, before tax (2)	3,288
Income tax expense	899		Income tax expense
Total reclassification, net of tax	$	2,389
(1) These AOCI components are included in the computation of net periodic benefit (income)/cost for pension and other postretirement benefits. See Note 9 for more information.
(2) There were no reclassifications relating to noncontrolling interest for the quarter ended March 31, 2024.

Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount

Total stock-based compensation expense included in the Condensed Consolidated Statements of Operations is as follows:

	For the Quarters Ended
(In thousands)	March 31, 2024		March 31, 2023
Cost of revenue	$	3,954	$	2,230
Sales and marketing	392		420
Product development	6,235		3,884
General and administrative	5,275		4,366
Total stock-based compensation expense	$	15,856	$	10,900